annual D&A:
$2.90M-$417.00K(-12.59%)Summary
- As of today (September 16, 2025), PTGX annual depreciation & amortization is $2.90 million, with the most recent change of -$417.00 thousand (-12.59%) on December 31, 2024.
- During the last 3 years, PTGX annual D&A has risen by +$120.00 thousand (+4.32%).
- PTGX annual D&A is now -14.07% below its all-time high of $3.37 million, reached on December 31, 2022.
Performance
PTGX Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$1.44M+$1.20M(+502.93%)Summary
- As of today (September 16, 2025), PTGX quarterly depreciation & amortization is $1.44 million, with the most recent change of +$1.20 million (+502.93%) on June 30, 2025.
- Over the past year, PTGX quarterly D&A has dropped by -$35.00 thousand (-2.37%).
- PTGX quarterly D&A is now -2.37% below its all-time high of $1.48 million, reached on June 30, 2024.
Performance
PTGX quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$2.86M-$35.00K(-1.21%)Summary
- As of today (September 16, 2025), PTGX TTM depreciation & amortization is $2.86 million, with the most recent change of -$35.00 thousand (-1.21%) on June 30, 2025.
- Over the past year, PTGX TTM D&A has dropped by -$508.00 thousand (-15.07%).
- PTGX TTM D&A is now -15.07% below its all-time high of $3.37 million, reached on June 30, 2024.
Performance
PTGX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
PTGX Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.6% | -2.4% | -15.1% |
| 3 y3 years | +4.3% | +70.9% | -10.5% |
| 5 y5 years | +14.7% | +123.4% | +9.2% |
PTGX Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -14.1% | +4.3% | -2.4% | +510.6% | -15.1% | +5.4% |
| 5 y | 5-year | -14.1% | +14.7% | -2.4% | +510.6% | -15.1% | +9.8% |
| alltime | all time | -14.1% | +1072.1% | -2.4% | +2384.5% | -15.1% | +4836.2% |
PTGX Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.44M(+502.9%) | $2.86M(-1.2%) |
| Mar 2025 | - | $239.00K(-55.4%) | $2.90M(+0.1%) |
| Dec 2024 | $2.90M(-12.6%) | $536.00K(-17.2%) | $2.90M(-9.3%) |
| Sep 2024 | - | $647.00K(-56.2%) | $3.19M(-5.3%) |
| Jun 2024 | - | $1.48M(+525.4%) | $3.37M(+24.1%) |
| Mar 2024 | - | $236.00K(-71.6%) | $2.72M(-18.0%) |
| Dec 2023 | $3.31M(-1.7%) | $832.00K(+0.6%) | $3.31M(-0.2%) |
| Sep 2023 | - | $827.00K(+0.7%) | $3.32M(-0.8%) |
| Jun 2023 | - | $821.00K(-1.3%) | $3.35M(-0.7%) |
| Mar 2023 | - | $832.00K(-1.0%) | $3.37M(-0.0%) |
| Dec 2022 | $3.37M(+21.4%) | $840.00K(-1.5%) | $3.37M(+0.6%) |
| Sep 2022 | - | $853.00K(+1.2%) | $3.35M(+4.7%) |
| Jun 2022 | - | $843.00K(+1.2%) | $3.20M(+7.2%) |
| Mar 2022 | - | $833.00K(+1.7%) | $2.98M(+7.5%) |
| Dec 2021 | $2.77M(+1.9%) | $819.00K(+16.3%) | $2.77M(+1.0%) |
| Sep 2021 | - | $704.00K(+12.1%) | $2.75M(+2.9%) |
| Jun 2021 | - | $628.00K(+0.6%) | $2.67M(-0.6%) |
| Mar 2021 | - | $624.00K(-21.1%) | $2.69M(-1.4%) |
| Dec 2020 | $2.72M | $791.00K(+26.4%) | $2.72M(+4.4%) |
| Sep 2020 | - | $626.00K(-2.9%) | $2.61M(-0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $645.00K(-2.4%) | $2.62M(+1.0%) |
| Mar 2020 | - | $661.00K(-2.2%) | $2.60M(+2.9%) |
| Dec 2019 | $2.52M(+378.9%) | $676.00K(+5.8%) | $2.52M(+27.7%) |
| Sep 2019 | - | $639.00K(+3.1%) | $1.98M(+32.8%) |
| Jun 2019 | - | $620.00K(+5.3%) | $1.49M(+43.4%) |
| Mar 2019 | - | $589.00K(+360.2%) | $1.04M(+97.0%) |
| Dec 2018 | $527.00K(+29.8%) | $128.00K(-15.2%) | $527.00K(+2.1%) |
| Sep 2018 | - | $151.00K(-11.2%) | $516.00K(+9.1%) |
| Jun 2018 | - | $170.00K(+117.9%) | $473.00K(+19.4%) |
| Mar 2018 | - | $78.00K(-33.3%) | $396.00K(-2.5%) |
| Dec 2017 | $406.00K(+28.1%) | $117.00K(+8.3%) | $406.00K(+11.5%) |
| Sep 2017 | - | $108.00K(+16.1%) | $364.00K(+7.4%) |
| Jun 2017 | - | $93.00K(+5.7%) | $339.00K(+2.1%) |
| Mar 2017 | - | $88.00K(+17.3%) | $332.00K(+4.7%) |
| Dec 2016 | $317.00K(+28.3%) | $75.00K(-9.6%) | $317.00K(-3.6%) |
| Sep 2016 | - | $83.00K(-3.5%) | $329.00K(+33.7%) |
| Jun 2016 | - | $86.00K(+17.8%) | $246.00K(+53.8%) |
| Mar 2016 | - | $73.00K(-16.1%) | $160.00K(+10.3%) |
| Dec 2015 | $247.00K(-4.3%) | $87.00K(+50.0%) | $145.00K(+150.0%) |
| Mar 2015 | - | $58.00K | $58.00K |
| Dec 2014 | $258.00K | - | - |
FAQ
- What is Protagonist Therapeutics, Inc. annual depreciation & amortization?
- What is the all time high annual D&A for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. annual D&A year-on-year change?
- What is Protagonist Therapeutics, Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. quarterly D&A year-on-year change?
- What is Protagonist Therapeutics, Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. TTM D&A year-on-year change?
What is Protagonist Therapeutics, Inc. annual depreciation & amortization?
The current annual D&A of PTGX is $2.90M
What is the all time high annual D&A for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high annual depreciation & amortization is $3.37M
What is Protagonist Therapeutics, Inc. annual D&A year-on-year change?
Over the past year, PTGX annual depreciation & amortization has changed by -$417.00K (-12.59%)
What is Protagonist Therapeutics, Inc. quarterly depreciation & amortization?
The current quarterly D&A of PTGX is $1.44M
What is the all time high quarterly D&A for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high quarterly depreciation & amortization is $1.48M
What is Protagonist Therapeutics, Inc. quarterly D&A year-on-year change?
Over the past year, PTGX quarterly depreciation & amortization has changed by -$35.00K (-2.37%)
What is Protagonist Therapeutics, Inc. TTM depreciation & amortization?
The current TTM D&A of PTGX is $2.86M
What is the all time high TTM D&A for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high TTM depreciation & amortization is $3.37M
What is Protagonist Therapeutics, Inc. TTM D&A year-on-year change?
Over the past year, PTGX TTM depreciation & amortization has changed by -$508.00K (-15.07%)